Akam Ramezani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akam Ramezani has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Amirhossein Ghaseminejad-Raeini
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Seyyed Hossein Shafiei
Orthopaedic Subspecialty Research Center, Sina University Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Akbar Fotouhi
Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Alexander Richard Vaccaro
Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, USA
1 shared publication Ali Anjomshoa
Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran. - Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran. & Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication- Ali Vasheghani-Farahani
Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Pain Research and Management
- Vol. 2026 (1) , e7121728
Functional Impact of Pain and Its Association With Sarcopenia in the Elderly: The Birjand Longitudinal Aging Study (BLAS)
Background: Sarcopenia, characterized by the loss of muscle mass and strength, is a prevalent geriatric condition associated with increased morbidity and healthcare burden. Understanding its multifactorial etiology is essential for effective prevention and management. Objectives: This study aimed to investigate the association between chronic pain and sarcopenia and to identify demographic, nutritional, and functional factors associated with sarcopenia in a cohort of older Iranian adults. Methods: A cross‐sectional analysis was conducted using baseline data from 1344 participants aged ≥ 60 years from the Birjand Longitudinal Aging Study (BLAS). Participants were classified into four groups based on the European Working Group on Sarcopenia in Older People‐version 2 (EWGSOP2) criteria: robust, probable sarcopenia, sarcopenia, and severe sarcopenia. Pain was assessed using the brief pain inventory (BPI), with pain severity score and pain interference score (BPI9) as primary variables. Multivariable and multinomial logistic regression models adjusted for socioeconomic, nutritional, and functional covariates were used to assess associations. Results: In logistic regression analyses, pain interference score was significantly associated with higher odds of sarcopenia across all models, including the fully adjusted model (OR = 1.24, 95% CI: 1.11–1.39, p < 0.001), whereas pain severity score was not associated with higher odds of sarcopenia in binary models ( p > 0.05). In multinomial logistic regression, pain interference score demonstrated a graded association with sarcopenia severity, with the strongest effect observed for severe sarcopenia (final model RRR = 1.32, 95% CI: 1.15–1.52, p < 0.001) and a moderate effect for probable sarcopenia (RRR = 1.13, 95% CI: 1.05–1.22, p = 0.003). The association between pain severity and sarcopenia severity was not significant in final adjusted model. Sensitivity analyses using an alternative sarcopenia definition confirmed these findings. Conclusion: Pain interference, rather than pain severity, is significantly associated with sarcopenia. These findings highlight the importance of addressing pain‐related functional limitations in efforts to prevent and manage sarcopenia, particularly in aging populations within low‐ and middle‐income countries.
- 1 January 2026
- Published by Wiley in Pain Research and Management
- Vol. 2026 (1) , e7121728
Open AccessFunctional Impact of Pain and Its Association With Sarcopenia in the Elderly: The Birjand Longitudinal Aging Study (BLAS)
Background: Sarcopenia, characterized by the loss of muscle mass and strength, is a prevalent geriatric condition associated with increased morbidity and healthcare burden. Understanding its multifactorial etiology is essential for effective prevention and management. Objectives: This study aimed to investigate the association between chronic pain and sarcopenia and to identify demographic, nutritional, and functional factors associated with sarcopenia in a cohort of older Iranian adults. Methods: A cross‐sectional analysis was conducted using baseline data from 1344 participants aged ≥ 60 years from the Birjand Longitudinal Aging Study (BLAS). Participants were classified into four groups based on the European Working Group on Sarcopenia in Older People‐version 2 (EWGSOP2) criteria: robust, probable sarcopenia, sarcopenia, and severe sarcopenia. Pain was assessed using the brief pain inventory (BPI), with pain severity score and pain interference score (BPI9) as primary variables. Multivariable and multinomial logistic regression models adjusted for socioeconomic, nutritional, and functional covariates were used to assess associations. Results: In logistic regression analyses, pain interference score was significantly associated with higher odds of sarcopenia across all models, including the fully adjusted model (OR = 1.24, 95% CI: 1.11–1.39, p < 0.001), whereas pain severity score was not associated with higher odds of sarcopenia in binary models ( p > 0.05). In multinomial logistic regression, pain interference score demonstrated a graded association with sarcopenia severity, with the strongest effect observed for severe sarcopenia (final model RRR = 1.32, 95% CI: 1.15–1.52, p < 0.001) and a moderate effect for probable sarcopenia (RRR = 1.13, 95% CI: 1.05–1.22, p = 0.003). The association between pain severity and sarcopenia severity was not significant in final adjusted model. Sensitivity analyses using an alternative sarcopenia definition confirmed these findings. Conclusion: Pain interference, rather than pain severity, is significantly associated with sarcopenia. These findings highlight the importance of addressing pain‐related functional limitations in efforts to prevent and manage sarcopenia, particularly in aging populations within low‐ and middle‐income countries.
- Open Access
- 1 January 2026
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 17 (1) , 1-24
Histopathological Effects of the Intrathecal Chondroitinase ABC Administration in Spinal Cord Injured Rats: A Systematic Review
Introduction: Chondroitinase ABC (ChABC) has been considered a potential treatment for spinal cord injury (SCI). We aim to identify and evaluate the histopathological effects of intrathecal ChABC administration in SCI rat models. Methods: We searched PubMed/MEDLINE, Scopus, Web of Science, Embase, and Cochrane Library for studies published from the inception of ...
- 1 January 2026
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 17 (1) , 1-24
Open AccessHistopathological Effects of the Intrathecal Chondroitinase ABC Administration in Spinal Cord Injured Rats: A Systematic Review
Introduction: Chondroitinase ABC (ChABC) has been considered a potential treatment for spinal cord injury (SCI). We aim to identify and evaluate the histopathological effects of intrathecal ChABC administration in SCI rat models. Methods: We searched PubMed/MEDLINE, Scopus, Web of Science, Embase, and Cochrane Library for studies published from the inception of ...
- Open Access
- 20 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11) , e71509
Successful Right Sided Subcutaneous Implantable Cardioverter‐Defibrillator Implantation in Situs Inversus Dextrocardia: A Case Report and Literature Review
This case report details the successful implantation of a subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in a 70‐year‐old male with situs inversus dextrocardia, a rare congenital condition where the heart and visceral organs are reversed. The patient, with a history of ischemic heart disease and severe left ventricular dysfunction (ejection fraction 25%), required primary prevention of sudden cardiac death. Due to anatomical challenges with transvenous ICD placement and no need for pacing or resynchronization, an S‐ICD was selected. Pre‐procedural screening was modified by reversing electrode positions to accommodate the right‐sided heart, ensuring eligibility across all sensing vectors. The S‐ICD was implanted using a two‐incision technique, positioning the generator in the right midaxillary line and the electrode along the left parasternal area. Defibrillation threshold testing confirmed effective termination of induced ventricular fibrillation with a 60 J shock. No complications occurred, and 1‐month follow‐up verified normal device function. This case demonstrates the adaptability and safety of S‐ICD implantation in dextrocardia, emphasizing tailored screening and procedural adjustments. A review of existing literature shows consistent success with S‐ICDs in similar patients, though device placement varies. This report adds to the evidence supporting S‐ICD use in complex congenital anatomies, providing valuable guidance for clinicians.
- 20 November 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (11) , e71509
Open AccessSuccessful Right Sided Subcutaneous Implantable Cardioverter‐Defibrillator Implantation in Situs Inversus Dextrocardia: A Case Report and Literature Review
This case report details the successful implantation of a subcutaneous implantable cardioverter‐defibrillator (S‐ICD) in a 70‐year‐old male with situs inversus dextrocardia, a rare congenital condition where the heart and visceral organs are reversed. The patient, with a history of ischemic heart disease and severe left ventricular dysfunction (ejection fraction 25%), required primary prevention of sudden cardiac death. Due to anatomical challenges with transvenous ICD placement and no need for pacing or resynchronization, an S‐ICD was selected. Pre‐procedural screening was modified by reversing electrode positions to accommodate the right‐sided heart, ensuring eligibility across all sensing vectors. The S‐ICD was implanted using a two‐incision technique, positioning the generator in the right midaxillary line and the electrode along the left parasternal area. Defibrillation threshold testing confirmed effective termination of induced ventricular fibrillation with a 60 J shock. No complications occurred, and 1‐month follow‐up verified normal device function. This case demonstrates the adaptability and safety of S‐ICD implantation in dextrocardia, emphasizing tailored screening and procedural adjustments. A review of existing literature shows consistent success with S‐ICDs in similar patients, though device placement varies. This report adds to the evidence supporting S‐ICD use in complex congenital anatomies, providing valuable guidance for clinicians.
- Open Access
- 1 October 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (4)
Local Antibiotic Delivery Systems and Their Applications in Orthopaedic Surgery
» Local antibiotic delivery systems are critical in managing periprosthetic and fracture-related infections, providing high local antibiotic concentrations without systemic side effects. Polymethyl methacrylate (PMMA), the first material to be mixed with antibiotics to perform local antibiotic therapy in orthopaedic history, offers reliable antibiotic delivery above the Minimum Inhibitory Concentration (MIC), typically used with heat-stable antibiotics such as vancomycin, tobramycin, and gentamicin. However, excessive antibiotics can weaken the cement, especially in total joint arthroplasty (TJA). When used for bone defects, a second surgery is often required to replace PMMA with bone grafts. » Calcium sulfate (CaSO 4 ) and hydroxyapatite (HA) combinations provide high antibiotic delivery, with CaSO 4 dissolving over time and CaSO 4 /HA offering better bone conversion than CaSO 4 . They are most effective in small, contained defects and can be mixed with relatively heat-unstable antibiotics. » Tricalcium phosphate (Ca 3 [PO 4 ] 2 ) cements are favored for their biocompatibility and biodegradability, enhancing osteoconductivity and allowing for prolonged antibiotic release. Although clinical studies on Ca 3 (PO 4 ) 2 as an antibiotic carrier are limited, vancomycin is commonly used, showing effective bone formation and infection control with a high bone defect cure and healing rate. » Hydrogels are 3D networks of hydrophilic polymers that absorb water and can form physical barriers against bacterial agents. Defensive antibacterial coatings (DAC) can be loaded with antibiotics and have shown lower postsurgery infection rates in arthroplasty. DACs reduce bacterial adhesion and can promote bone healing when combined with osteogenic factors, while being bioabsorbable and compatible with living tissue. » Antibiotic-impregnated bone grafts combine effective local antibiotic delivery with maximum bone healing potential, particularly for those pretreated with induced membranes. Intramedullary harvest offers an unlimited source of bone graft material.
- 1 October 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (4)
Open AccessLocal Antibiotic Delivery Systems and Their Applications in Orthopaedic Surgery
» Local antibiotic delivery systems are critical in managing periprosthetic and fracture-related infections, providing high local antibiotic concentrations without systemic side effects. Polymethyl methacrylate (PMMA), the first material to be mixed with antibiotics to perform local antibiotic therapy in orthopaedic history, offers reliable antibiotic delivery above the Minimum Inhibitory Concentration (MIC), typically used with heat-stable antibiotics such as vancomycin, tobramycin, and gentamicin. However, excessive antibiotics can weaken the cement, especially in total joint arthroplasty (TJA). When used for bone defects, a second surgery is often required to replace PMMA with bone grafts. » Calcium sulfate (CaSO 4 ) and hydroxyapatite (HA) combinations provide high antibiotic delivery, with CaSO 4 dissolving over time and CaSO 4 /HA offering better bone conversion than CaSO 4 . They are most effective in small, contained defects and can be mixed with relatively heat-unstable antibiotics. » Tricalcium phosphate (Ca 3 [PO 4 ] 2 ) cements are favored for their biocompatibility and biodegradability, enhancing osteoconductivity and allowing for prolonged antibiotic release. Although clinical studies on Ca 3 (PO 4 ) 2 as an antibiotic carrier are limited, vancomycin is commonly used, showing effective bone formation and infection control with a high bone defect cure and healing rate. » Hydrogels are 3D networks of hydrophilic polymers that absorb water and can form physical barriers against bacterial agents. Defensive antibacterial coatings (DAC) can be loaded with antibiotics and have shown lower postsurgery infection rates in arthroplasty. DACs reduce bacterial adhesion and can promote bone healing when combined with osteogenic factors, while being bioabsorbable and compatible with living tissue. » Antibiotic-impregnated bone grafts combine effective local antibiotic delivery with maximum bone healing potential, particularly for those pretreated with induced membranes. Intramedullary harvest offers an unlimited source of bone graft material.
- Open Access
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Association Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by nonscarring hair loss, affecting up to 2% of the population. While primarily a dermatological condition, recent studies have explored possible systemic associations, including cardiovascular involvement. Troponins have been a focal point in examining cardiovascular risks in various autoimmune diseases. This study aims to evaluate and compare High‐sensitivity cardiac troponin T (hs‐cTnT) levels in patients with AA against healthy controls to explore potential cardiovascular risk associations. Methods: In this cross‐sectional study, 45 patients with AA and 45 age‐ and sex‐matched healthy individuals were enrolled. Demographic characteristics of patients, medical history, and lifestyle factors were gathered through questionnaires. Patient blood samples were collected, and hs‐cTnT levels were determined using high‐sensitivity immunoassays to provide accurate measurements. Statistical analyses were conducted using the SPSS software. Statistical significance was set at p < 0.05. Results: Both study groups comprised of 26 male and 19 female participants. The mean age of the AA group was 37.33 ± 12.49, and the mean age of the control group was 36.22 ± 12.28. Of the patients with AA, 73.3% had patchy areata, 11.1% had totalis areata, and 15.6% had universalis areata. The mean hs‐cTnT levels in the AA group were 4.29 ± 3.54 and 2.87 ± 2.05 for the control group ( p value = 0.04). The disease duration exhibited a positive correlation with elevated concentrations of hs‐cTnT ( p value < 0.001). Conclusion: Elevated hs‐cTnT levels in patients with AA strengthen the link between AA and cardiovascular diseases. Additional research is needed to clarify the relationship between AA and elevated cardiac markers. Studies with larger sample sizes, long‐term follow‐ups, and comprehensive cardiac assessments (including laboratory tests and imaging techniques) can provide more definitive evidence to determine the cause of the increased marker levels.
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Open AccessAssociation Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
Background: Alopecia areata (AA) is a common autoimmune disorder characterized by nonscarring hair loss, affecting up to 2% of the population. While primarily a dermatological condition, recent studies have explored possible systemic associations, including cardiovascular involvement. Troponins have been a focal point in examining cardiovascular risks in various autoimmune diseases. This study aims to evaluate and compare High‐sensitivity cardiac troponin T (hs‐cTnT) levels in patients with AA against healthy controls to explore potential cardiovascular risk associations. Methods: In this cross‐sectional study, 45 patients with AA and 45 age‐ and sex‐matched healthy individuals were enrolled. Demographic characteristics of patients, medical history, and lifestyle factors were gathered through questionnaires. Patient blood samples were collected, and hs‐cTnT levels were determined using high‐sensitivity immunoassays to provide accurate measurements. Statistical analyses were conducted using the SPSS software. Statistical significance was set at p < 0.05. Results: Both study groups comprised of 26 male and 19 female participants. The mean age of the AA group was 37.33 ± 12.49, and the mean age of the control group was 36.22 ± 12.28. Of the patients with AA, 73.3% had patchy areata, 11.1% had totalis areata, and 15.6% had universalis areata. The mean hs‐cTnT levels in the AA group were 4.29 ± 3.54 and 2.87 ± 2.05 for the control group ( p value = 0.04). The disease duration exhibited a positive correlation with elevated concentrations of hs‐cTnT ( p value < 0.001). Conclusion: Elevated hs‐cTnT levels in patients with AA strengthen the link between AA and cardiovascular diseases. Additional research is needed to clarify the relationship between AA and elevated cardiac markers. Studies with larger sample sizes, long‐term follow‐ups, and comprehensive cardiac assessments (including laboratory tests and imaging techniques) can provide more definitive evidence to determine the cause of the increased marker levels.
- 4 July 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (8) , 821-831
Marital Quality-A Neglected Player in the Prevention of Cardiovascular Diseases: A Systematic Review of Longitudinal Studies
Purpose of Review Marital quality (MQ) is a psychosocial factor that has been neglected in cardiovascular prevention guidelines, although its association with cardiovascular diseases has been identified in several studies. Therefore, we aim to investigate how MQ either in positive or negative dimensions affect different cardiovascular risk factors and diseases. Recent Findings We systematically searched different databases in September 2023 for longitudinal studies conducted to assess the contribution of MQ to well-established cardiovascular risk factors and diseases. Two independent researchers screened studies and carried out data extraction and quality assessment of included ones. From 12,175 potential studies screened, 40 were included. The presence of significant heterogeneity in methodology, follow-up, and subsequent effect estimates made it unfeasible to do a meta-analysis. Despite the variation, most studies found a significant association of negative MQ measures with physical inactivity (2/2), high levels of smoking (4/5) and alcohol (3/3) use, increased metabolic syndrome risk (3/3), elevated type 2 diabetes mellitus (T2DM) risk and poor T2DM management (3/6), elevated cardiovascular disease risk and progression (9/11), increased body weight and obesity risk (2/3), elevated blood pressure and hypertension risk (7/8). Positive MQ measures were mainly associated with improvement in blood pressure control (2/2), reduced T2DM risk and its good management (1/1), reduced body weight and obesity risk (2/2), and increased survival in cardiovascular diseases (4/4). Summary Based on current evidence, MQ seems to play a crucial role in developing established cardiovascular risk factors and diseases and is worth considering in preventive strategies. Graphical Abstract
- 4 July 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (8) , 821-831
Marital Quality-A Neglected Player in the Prevention of Cardiovascular Diseases: A Systematic Review of Longitudinal Studies
Purpose of Review Marital quality (MQ) is a psychosocial factor that has been neglected in cardiovascular prevention guidelines, although its association with cardiovascular diseases has been identified in several studies. Therefore, we aim to investigate how MQ either in positive or negative dimensions affect different cardiovascular risk factors and diseases. Recent Findings We systematically searched different databases in September 2023 for longitudinal studies conducted to assess the contribution of MQ to well-established cardiovascular risk factors and diseases. Two independent researchers screened studies and carried out data extraction and quality assessment of included ones. From 12,175 potential studies screened, 40 were included. The presence of significant heterogeneity in methodology, follow-up, and subsequent effect estimates made it unfeasible to do a meta-analysis. Despite the variation, most studies found a significant association of negative MQ measures with physical inactivity (2/2), high levels of smoking (4/5) and alcohol (3/3) use, increased metabolic syndrome risk (3/3), elevated type 2 diabetes mellitus (T2DM) risk and poor T2DM management (3/6), elevated cardiovascular disease risk and progression (9/11), increased body weight and obesity risk (2/3), elevated blood pressure and hypertension risk (7/8). Positive MQ measures were mainly associated with improvement in blood pressure control (2/2), reduced T2DM risk and its good management (1/1), reduced body weight and obesity risk (2/2), and increased survival in cardiovascular diseases (4/4). Summary Based on current evidence, MQ seems to play a crucial role in developing established cardiovascular risk factors and diseases and is worth considering in preventive strategies. Graphical Abstract
- Open Access
- 29 April 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (6) , 3423-3431
Statin use in total joint arthroplasty: a systematic review
Introduction: There has been increased interest in the use of Statins in total hip and knee arthroplasty (THA and TKA) patients to improve outcomes and reduce postoperative complications. This study was performed to systematically review the evidence on Statin use in total joint arthroplasty, specifically its benefits and complications. Methods: Adhering to the PRISMA guidelines, a systematic review of PubMed, Embase, Scopus, Web of Science, and the Cochrane database was performed to find studies reporting on the effects of Statin use on outcomes of THA and TKA. Two authors independently selected relevant papers to include. Results: A total of 18 papers were included in the final analysis. Most were retrospective studies, with heterogeneous patient selection and outcome measures. The evidence on the risks and benefits of Statin use on outcomes of total joint arthroplasty was very limited and heterogeneous. Studies were focusing on perioperative cardiac outcomes, clinical outcomes and complications, renal, pulmonary, and gastrointestinal outcomes. Due to the heterogeneity of reported data, a formal meta-analysis was not possible. Conclusions: There is some evidence in the literature suggesting that perioperative use of Statins, especially in Statin-naïve patients, may reduce cardiac (e.g. atrial fibrillation) and noncardiac (e.g. delirium) complications, while not increasing the risk of muscle or liver toxicity. The authors also found low levels of evidence that Statin use may reduce the long-term risk for revision surgery and osteolysis.
- 29 April 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (6) , 3423-3431
Open AccessStatin use in total joint arthroplasty: a systematic review
Introduction: There has been increased interest in the use of Statins in total hip and knee arthroplasty (THA and TKA) patients to improve outcomes and reduce postoperative complications. This study was performed to systematically review the evidence on Statin use in total joint arthroplasty, specifically its benefits and complications. Methods: Adhering to the PRISMA guidelines, a systematic review of PubMed, Embase, Scopus, Web of Science, and the Cochrane database was performed to find studies reporting on the effects of Statin use on outcomes of THA and TKA. Two authors independently selected relevant papers to include. Results: A total of 18 papers were included in the final analysis. Most were retrospective studies, with heterogeneous patient selection and outcome measures. The evidence on the risks and benefits of Statin use on outcomes of total joint arthroplasty was very limited and heterogeneous. Studies were focusing on perioperative cardiac outcomes, clinical outcomes and complications, renal, pulmonary, and gastrointestinal outcomes. Due to the heterogeneity of reported data, a formal meta-analysis was not possible. Conclusions: There is some evidence in the literature suggesting that perioperative use of Statins, especially in Statin-naïve patients, may reduce cardiac (e.g. atrial fibrillation) and noncardiac (e.g. delirium) complications, while not increasing the risk of muscle or liver toxicity. The authors also found low levels of evidence that Statin use may reduce the long-term risk for revision surgery and osteolysis.
- Open Access
- 11 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 703-711
Factors associated with postoperative quality of life in patients with intertrochanteric fracture
Introduction: Intertrochanteric fractures, which make up the majority of hip fractures, are a common and serious injury that can greatly impact quality of life. Treatment of such fractures comprises nearly half of the costs contributed to hip fractures. Identifying the factors affecting the functional outcomes of patients after intertrochanteric fracture can help to reduce burden of disease for the patient and healthcare system. The present study investigated the factors underlying the worsening of short form-36 score (SF-36) scores for intertrochanteric fracture patients. Materials and methods: This retrospective cohort study was designed based on data from our clinic. All consecutive patients with intertrochanteric fractures from November 2016 to September 2020 were reviewed. The exclusion criteria included patients having a second injury or having had previous surgery related to the hip and those with incomplete data. Baseline characteristics of patients were extracted from annotated records. The lab data were acquired from the electronic hospital system. The outcomes were SF-36 scores obtained by phone contact with patients or their families. Statistical analysis was conducted in SPSS. Results: A total of 310 patients were included in the current study. The female gender, advanced age, history of diabetes, thyroid malfunction, cancer, osteoporosis, anticoagulant use and blood transfusion were identified as risk factors for lower SF-36 scores. Low levels of haemoglobin before surgery, blood urea nitrogen (BUN), BUN/Creatinine, and white blood count values correlated with lower SF-36 scores. Conclusion: Numerous contextual variables affected the functional outcomes of the patients. Consideration of these factors could be helpful in reducing costs and improving the quality of life for intertrochanteric fracture patients.
- 11 December 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (2) , 703-711
Open AccessFactors associated with postoperative quality of life in patients with intertrochanteric fracture
Introduction: Intertrochanteric fractures, which make up the majority of hip fractures, are a common and serious injury that can greatly impact quality of life. Treatment of such fractures comprises nearly half of the costs contributed to hip fractures. Identifying the factors affecting the functional outcomes of patients after intertrochanteric fracture can help to reduce burden of disease for the patient and healthcare system. The present study investigated the factors underlying the worsening of short form-36 score (SF-36) scores for intertrochanteric fracture patients. Materials and methods: This retrospective cohort study was designed based on data from our clinic. All consecutive patients with intertrochanteric fractures from November 2016 to September 2020 were reviewed. The exclusion criteria included patients having a second injury or having had previous surgery related to the hip and those with incomplete data. Baseline characteristics of patients were extracted from annotated records. The lab data were acquired from the electronic hospital system. The outcomes were SF-36 scores obtained by phone contact with patients or their families. Statistical analysis was conducted in SPSS. Results: A total of 310 patients were included in the current study. The female gender, advanced age, history of diabetes, thyroid malfunction, cancer, osteoporosis, anticoagulant use and blood transfusion were identified as risk factors for lower SF-36 scores. Low levels of haemoglobin before surgery, blood urea nitrogen (BUN), BUN/Creatinine, and white blood count values correlated with lower SF-36 scores. Conclusion: Numerous contextual variables affected the functional outcomes of the patients. Consideration of these factors could be helpful in reducing costs and improving the quality of life for intertrochanteric fracture patients.